Role of the community pharmacist in detecting frailty and spatio-temporal disorientation among community-dwelling older people in France
- PMID: 32754888
- DOI: 10.1007/s40520-020-01673-2
Role of the community pharmacist in detecting frailty and spatio-temporal disorientation among community-dwelling older people in France
Abstract
Background: Many older community-dwelling subjects may be frail and/or disoriented, putting them at risk of adverse outcomes. We investigated the prevalence of frailty and spatiotemporal disorientation among patients aged > 65 years collecting regular medication at a community pharmacy.
Methods: Prospective, cross-sectional study of geriatric evaluation in 218 community pharmacies in France. Regular customers aged > 65 years attending the pharmacy to receive ≥ 1 prescription drug were eligible. Spatio-temporal disorientation was assessed using a 4-item screening test; subjects were considered disoriented if they had ≥ 1 incorrect answers. Frailty was evaluated using the Short Emergency Geriatric Assessment (SEGA) grid. Subjects were considered as not frail (score < 8), or frail/very frail (score of 8 or more).
Results: 4090 subjects were included, average age 77.5 ± 7.6 years, 60.1% females. Overall, 1025 (25%) were frail/very frail, and 384 (9.4%) were disoriented in space or time. On average, subjects were taking 5.4 ± 3.5 medications per day. Among non-frail patients, 116/3065 (3.8%) were disoriented, of whom 87 (87/116, 75%) managed their medication alone. Among frail/very frail patients, 268/1025 (26.1%) were disoriented, of whom 46 (46/268, 16.8%) managed their medication alone. The majority of patients (77.9%) collected their medication alone at the pharmacy, but significantly fewer frail patients came to collect their drugs alone (p < 0.001).
Conclusion: It is feasible for community pharmacists to detect disorientation and frailty among older patients. A quarter of subjects were frail/very frail, and 3.2% were disoriented yet managing their drugs alone. Additional social support should be envisaged for these subjects.
Keywords: Cognitive disorders; Community pharmacy services; Frailty; Geriatrics; Pharmacists; Pharmacoepidemiology.
References
-
- Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people. Lancet 381:752–762. https://doi.org/10.1016/S0140-6736(12)62167-9 - DOI - PubMed
-
- Fried LP, Ferrucci L, Darer J et al (2004) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 59:255–263. https://doi.org/10.1093/gerona/59.3.m255 - DOI - PubMed
-
- Fairhall N, Langron C, Sherrington C et al (2011) Treating frailty—a practical guide. BMC Med 9:83. https://doi.org/10.1186/1741-7015-9-83 - DOI - PubMed - PMC
-
- Ng TP, Feng L, Nyunt MS et al (2015) Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial. Am J Med 128:e1221. https://doi.org/10.1016/j.amjmed.2015.06.017 - DOI
-
- Puts MTE, Toubasi S, Andrew MK et al (2017) Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policies. Age Ageing 46:383–392. https://doi.org/10.1093/ageing/afw247 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
